Changes in antimicrobial resistance and outcomes of health care–associated infections
Göster/Aç
Erişim
info:eu-repo/semantics/openAccessTarih
14.02.2021Yazar
Aydın, MehtapAzak, Emel
Bilgin, Hüseyin
Menekşe, Şirin
Asan, Ali
Elmaslar Mert, Habibe Tülin
Yuluğkural, Zerrin
Altunal, Lütfiye Nilsun
Ataman Hatipoğlu, Çiğdem
Tuncer Ertem, Günay
Sargın Altunok, Elif
Demirkaya, Melike Hamiyet
Alkan Çeviker, Sevil
Akgül, Fethiye
Memiş, Zeynep
Konya, Petek
Azap, Alpay
Aydın, Güle
Korkmaz, Derya
Karakoç, Zehra Çağla
Yapar, Derya
Karakeçili, Faruk
Günal, Özgür
Keske, Şiran
Kapmaz, Mahir
Kader, Çiğdem
Demirel, Aslıhan
Ergönül, Önder
Üst veri
Tüm öğe kaydını gösterKünye
Aydın, M., Azak, E., Bilgin, H., Menekse, S., Asan, A., Mert, H. T. E., ... & Ergönül, Ö. (2021). Changes in antimicrobial resistance and outcomes of health care–associated infections. European Journal of Clinical Microbiology & Infectious Diseases, 40(8), 1737-1742.Özet
To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we
conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to
25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day
fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018.
Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus
methicillin, resistance increased from 31 to 41%.
Kaynak
European Journal of Clinical Microbiology and Infectious DiseasesCilt
40Sayı
8Koleksiyonlar
- Yayın Koleksiyonu [29]